KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Payables (2016 - 2026)

Medtronic (MDT) has disclosed Payables for 13 consecutive years, with $2.6 billion as the latest value for Q1 2026.

  • Quarterly Payables rose 12.38% to $2.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.6 billion through Jan 2026, up 12.38% year-over-year, with the annual reading at $2.4 billion for FY2025, 1.62% up from the prior year.
  • Payables hit $2.6 billion in Q1 2026 for Medtronic, roughly flat from $2.6 billion in the prior quarter.
  • In the past five years, Payables ranged from a high of $2.7 billion in Q2 2023 to a low of $2.0 billion in Q1 2022.
  • Historically, Payables has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2025.
  • Biggest five-year swings in Payables: increased 16.96% in 2023 and later fell 9.82% in 2024.
  • Year by year, Payables stood at $2.2 billion in 2022, then fell by 1.09% to $2.2 billion in 2023, then rose by 9.29% to $2.4 billion in 2024, then increased by 8.63% to $2.6 billion in 2025, then fell by 0.46% to $2.6 billion in 2026.
  • Business Quant data shows Payables for MDT at $2.6 billion in Q1 2026, $2.6 billion in Q4 2025, and $2.6 billion in Q3 2025.